NCT06067503 2026-04-13
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
Clinical Trials
11 trialsNCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
NCT07142226 2026-03-18
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
CHA University
Recruiting
NCT07151118 2026-03-18
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
CHA University
Recruiting
NCT03265496 2026-03-17
CONCORDE
Centre Oscar Lambret
Phase NA Terminated
NCT07432308 2026-03-06
Liquid biopsy
Institute of Oncology Ljubljana
Phase NA Completed
NCT07418125 2026-02-18
GALIA
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT05774561 2026-02-12
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
The Institute of Molecular and Translational Medicine, Czech Republic
Recruiting
NCT06068075 2026-01-22
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT07358715 2026-01-22
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
National University Hospital, Singapore
Phase NA Recruiting
NCT05708599 2026-01-21
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
Boehringer Ingelheim
Phase NA Active not recruiting